Cargando…
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term “hyperferritinemic syndromes” and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic s...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199723/ https://www.ncbi.nlm.nih.gov/pubmed/32387470 http://dx.doi.org/10.1016/j.autrev.2020.102573 |
_version_ | 1783529203090587648 |
---|---|
author | Colafrancesco, Serena Alessandri, Cristiano Conti, Fabrizio Priori, Roberta |
author_facet | Colafrancesco, Serena Alessandri, Cristiano Conti, Fabrizio Priori, Roberta |
author_sort | Colafrancesco, Serena |
collection | PubMed |
description | The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term “hyperferritinemic syndromes” and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic inflammatory reaction and “hyperferritinemic syndromes” are all characterized by high serum ferritin and a life-threatening hyper-inflammation sustained by a cytokines storm which eventually leads to multi-organ failure. In this review, we analyze the possible epidemiological and molecular mechanisms responsible for hyper-inflammation in patients with severe COVID-19 and we underline the similarities between this condition and “hyperferritinemic syndromes” which would allow considering severe COVID-19 as a fifth member of this spectrum of inflammatory conditions. |
format | Online Article Text |
id | pubmed-7199723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71997232020-05-06 COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Colafrancesco, Serena Alessandri, Cristiano Conti, Fabrizio Priori, Roberta Autoimmun Rev Article The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term “hyperferritinemic syndromes” and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic inflammatory reaction and “hyperferritinemic syndromes” are all characterized by high serum ferritin and a life-threatening hyper-inflammation sustained by a cytokines storm which eventually leads to multi-organ failure. In this review, we analyze the possible epidemiological and molecular mechanisms responsible for hyper-inflammation in patients with severe COVID-19 and we underline the similarities between this condition and “hyperferritinemic syndromes” which would allow considering severe COVID-19 as a fifth member of this spectrum of inflammatory conditions. Elsevier B.V. 2020-07 2020-05-05 /pmc/articles/PMC7199723/ /pubmed/32387470 http://dx.doi.org/10.1016/j.autrev.2020.102573 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Colafrancesco, Serena Alessandri, Cristiano Conti, Fabrizio Priori, Roberta COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? |
title | COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? |
title_full | COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? |
title_fullStr | COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? |
title_full_unstemmed | COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? |
title_short | COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? |
title_sort | covid-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199723/ https://www.ncbi.nlm.nih.gov/pubmed/32387470 http://dx.doi.org/10.1016/j.autrev.2020.102573 |
work_keys_str_mv | AT colafrancescoserena covid19gonebadanewcharacterinthespectrumofthehyperferritinemicsyndrome AT alessandricristiano covid19gonebadanewcharacterinthespectrumofthehyperferritinemicsyndrome AT contifabrizio covid19gonebadanewcharacterinthespectrumofthehyperferritinemicsyndrome AT prioriroberta covid19gonebadanewcharacterinthespectrumofthehyperferritinemicsyndrome |